A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period

Clinical trial NCT00560508 · COMPLETED

Trial details

NCT number: NCT00560508
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2007-11-01
Primary completion: 2009-11-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.